US investors are one of a kind:
- 99% of them are in fact traders.
- Those sick creatures have plenty of energy and time, and cannot live buying/selling 1-2 stocks a day. So they keep buying and seling under different "gain types" motivations, using "quant" trading or "fast" trading", besides the simply day traders "tricks". If 50% of them make money in a day, the other 50% of them lose money. They get anyhow the fees from customers, and bonuses from mngmts.
In a word, today's traders just mess up the markets, and they a legal/protected (like rare animals). And shorting is very legal and pushed for, even being in fact like taking the bricks from a building under consturction. No, this is not a felony, it is very legal. The Chinese do not allow it, but they a constantly forced by us to accept it (to be able to short them down if we feel so). I love it!
They woudn't know how to invest even for their own mothers.
What I wanted in my posts, was (directly and indirectly) to get data and more of their opinions. That indirect mode is sometimes misguiding people.
Something direct now.
As an investor and (involuntary) trader, I consider shorting shares as a dishonest activity. That is because it is like taking bricks from a building under construction.
So, a_sky_pilot, from your last 2 emails (Dr PSS and Dr.Ji seem pretty tight) and the one before (your reply to "So, did we buy SRNE for 7% of the NK shares, as kcac135 says?"), you are surprised that there are only 7% instead of 40% of one IPO per one SRNE share?
So, did we buy SRNE for 7% of the NK shares, as kcac135 says?
kcac135: "SRNE will own just over 7% of the NK shares". If true, it is not much. And Dr. Soon-Shiong will not have any reason to manage SRNE. Owning SRNE as a replacement for the real IPO, and to have the Dr. Soon-Shiong's management, seems to me an odd idea in the above context.
And IF investors do not buy SRNE, there is no mechanism to get up the value of SRNE when the IPO goes up.
My 2 cents..
About ADXS, they have "almost all". They are focused, have IP and experienced people at all levels, but do not have a Dr. Soon-Shiong. I understand that.
I asked just in case you have your own insight/opinion about them.
Thank you mulanoom2007 - this IS a reasoning. And it is reasonable, even for me... And one of the parameters for a company IS the management. I bought some more SRNE.
What do you think about ADXS? Theoretically they have all. Or?
Thank you, MS.
Thank you kcac135.
It is something, depending on many parameters. I understand that this board approach is to buy SRNA to get to the 40% of the IPO (like Yahoo! and Alibaba). If many people will do this, SRNE will reflect the price of NK. If not many, not much similarity. But it is practically the only (indirect) shot at NK. The field (as many other) is already crowded (Juno Therapeutics, Celgene, etc.), but all the fields are crowded today.
We'll see. Good look to us!
OK, you guys assume that it will be like the Yahoo! and Alibaba game.
Thank you for your typical lack of kindness.
NantPharma, founded by Dr. Patrick Soon-Shiong and a member of the NantWorks ecosystem of companies, agreed to acquire the rights to Cynviloq through the acquisition of Igdrasol, Inc., a wholly-owned subsidiary of Sorrento, which has been developing Cynviloq (paclitaxel nanoparticle polymeric micelle) in a bio-equivalence trial.
I WANT TO BUY more SRNE, BUT you did not give me the answer on how SRNE has value after selling "the rights to Cynviloq" and taking the money (OK, not as a slump sum, but it signed the contract)?
I RESPECTFULLY AND KINDLY ASK YOU to clarify me this, to be a real believer and buy more. Thank you for your time.
mdr0418 and masterwilight55, you can write only insults and predictions. And Not a Clarification as I poltely asked.
Low quality people.
Please clarify who is WE: The people working in Dr. Soon-Shiong's companies (from now, not the ones he sold to make his billions), or people working in SRNE?
How is SRNE not an empty shell after selling out its Intelectual Property?
The CEO of SRNE sings "thank you Dr. Soon-Shiong!" songs, after taking 1.2 billions. Maybe he has already writen an 1 billion bonus to himself! The value of SRNE is the same - look at it! They don't have even the right to use the technology which is nor their anymore.
Veryy odd things!
Give me some real proof, and don't re-copy the already published documents.
Otherwise, all of you are in fact short on SRNE, and pushers!
Sorry arc0702, but your data about ADVAXIS is mistaken. No AGIOS in their Co. Hope that the rest of your brought data are correct (e.g. about SRNE). Now maybe you guys understand why I threw that "empty shell" question. All 100% positive, no question asked, nice is nice, but is it true?
If this was directed to me (mms) sterlingfish, I see you are less smart then I thought. In this case your thinking is not synthetic, it is just the thinking of o simple mind. Some education and a more elevated environment could help. Good luck!
If this is "clouds", at least 2 words about why, please. Tkx.
After NantPharma acquired "the rights to Cynviloq through the acquisition of Igdrasol", Sorrento is like an empty shell; "it has the option to co-develop and/or co-market Cynviloq on terms to be negotiated.", but this is in the future, and with an IF!
I hope I am wrong, but these are the contract terms.
My audio is messed-up, please, what the CEO said in "BOX CEO: I'm doing this when the stock lockup expires". Thank you very much.